Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure

E-ISSN： 1873-4316|13|13|2522-2531

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.13, 2012-10, pp. : 2522-2531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of specificity of antibodies directed against human beta-adrenergic receptors

By Hamdani Nazha

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 379, Iss. 6, 2009-06 ,pp. : 637-637

Springer Publishing Company

Access to resources Recommend Favorite

Protective effect of a GRK5 polymorphismon heart failure and its interaction with &bgr;β-adrenergic receptor antagonists

By Eijgelsheim Mark Visser Loes E Uitterlinden Andréé G Stricker Bruno H Ch

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1551-1555

Future Medicine

Access to resources Recommend Favorite

Therapeutic Implications of Beta-Adrenergic Receptor Pharmacodynamic Properties

Current Clinical Pharmacology, Vol. 3, Iss. 3, 2008-09 ,pp. : 174-184

Bentham Science Publishers

Access to resources Recommend Favorite

Beta-Adrenergic Antagonists: Indications and Potential Immunomodulatory Side Effects in the Critically Ill

Current Medicinal Chemistry, Vol. 16, Iss. 9, 2009-03 ,pp. : 1082-1090

Bentham Science Publishers

Access to resources Recommend Favorite

Which Beta-Blocker is Most Effective in Heart Failure?

By Remme Willem

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 351-358

Springer Publishing Company

Access to resources Recommend Favorite